Trump plans to fire FDA Commissioner Marty Makary following months of turmoil inside the agency, Bloomberg Politics reported Thursday, citing a person familiar with the matter.
The strategic read here is simple: Makary was brought in as a reform-friendly outsider, but disorder at FDA has become a liability the White House can no longer absorb. Firing him doesn't solve the underlying chaos — it signals that the chaos is the point. A rudderless FDA means slower drug approvals, weaker pandemic-prep capacity, and an agency too destabilized to push back on anything.
Who benefits: anyone who wants pharmaceutical and food-safety oversight neutered without the political cost of formally abolishing it. Robert F. Kennedy Jr.'s HHS sits directly above FDA. Watch who gets nominated next — that name will tell you everything about the actual operational agenda.